| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 646 | 727 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 21 | 45 | 140 | 26 | - | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -21 | 601 | 587 | -26 | - | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -21 | 601 | 587 | -26 | - | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioagroser S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.651 | 48.879 | 48.443 | 47.554 | - | 45.749 | 44.734 | 44.873 | 44.737 | 44.487 |
| Current Assets | 3.538 | 3.802 | 3.059 | 2.977 | - | 2.864 | 2.801 | 2.809 | 2.801 | 2.785 |
| Inventories | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 340 | 334 | - | 321 | 314 | 315 | 314 | 312 |
| Cash | 3.538 | 3.802 | 2.720 | 2.644 | - | 2.543 | 2.487 | 2.495 | 2.487 | 2.473 |
| Shareholders Funds | 5.018 | 5.568 | 5.991 | 5.855 | - | 5.633 | 5.508 | 5.525 | 5.508 | 5.477 |
| Social Capital | 5.039 | 4.988 | 4.904 | 4.814 | - | 4.631 | 4.528 | 4.542 | 4.528 | 4.503 |
| Debts | 171 | 47.113 | 45.511 | 44.676 | - | 42.980 | 42.027 | 42.158 | 42.030 | 41.795 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Bioagroser S.r.l.